| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 7e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |